UAB-NDRI-SUBSTANCE ABUSE ICOHRTA IN UKRAINE

乌克兰 UAB-NDRI-药物滥用 ICOHRTA

基本信息

批准号：
6897451
负责人：
NALINI SATHIAKUMAR
金额：
$ 27.39万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2001
资助国家：
美国
起止时间：
2001-09-27 至 2007-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/6897451
关键词：
AIDS Commonwealth of Independent States Europe HIV infections disease /disorder prevention /control epidemiology international cooperation intravenous drug abuse sexually transmitted diseases substance abuse related disorder tuberculosis

项目摘要

DESCRIPTION (provided by applicant): Our proposal is a collaborative effort between the University of Alabama at Birmingham (UAB), the National Development and Research Institute, Inc. (NDRI) and the Pirogov Medical University in Vinnitsa, Ukraine. The purpose of this initiative is to strengthen and sustain, through collaborative training and research, the ability of Ukrainian scientists, physicians, and public health practitioners to contribute to clinical, operational and health services research focused on substance abuse treatment and prevention, and prevention and control of the related epidemics of human immunodeficiency virus (HIV) infection with a particular focus on injection drug use (IDU) and the attendant epidemics of human immunodeficiency virus (HIV), sexually transmitted diseases (STD), and tuberculosis (TB). To develop the Pirogov Medical University into a regional center for training and research excellence, we have designed a program of training that will prepare Pirogov scholars and students to address all the key issues pertaining to IDU-related clinical, operational, and health services research in Ukraine as well as to participate effectively in research that addresses global problems in HIV/STD/TB prevention and control emphasizing communities with substantial IDU populations. Our training program is multidisciplinary and includes clinical research, international health, epidemiology, health behavior, biostatistics, health policy, and key principles in both intervention and treatment research. Our research goals are to better understand the IDU epidemic in Ukraine in order to guide treatment and control strategies, as well as to upgrade evidence-based approaches to the closely related epidemics of HIV infection, STDs, and TB in the services of their control and prevention. The selection of the Pirogov Medical University as the key training center was done with four key factors in mind: (1) Pirogov is one of the premier medical schools in all of eastern Europe; (2) Fully one-quarter of Pirogov?s medical students come from outside the Ukraine, making it an international training site; (3) Pirogov and UAB have been collaborating on research and training for over two years and have a written, substantive agreement to collaborate, co-signed by the President of Pirogov Medical University and the Provost of UAB in Birmingham in March 2000; and (4) UAB and NDRI have complementary expertise and have a close working relationship.

描述（由申请人提供）：我们的建议是协作的努力在阿拉巴马大学伯明翰大学（UAB）之间，国家发展和研究所，Inc。（NDRI）和Pirogov医科大学 Vinnitsa，乌克兰。该计划的目的是加强和维持，通过协作培训和研究，乌克兰人的能力科学家，医师和公共卫生从业人员为临床，运营和卫生服务研究的重点是滥用药物治疗和预防以及相关流行病的预防和控制人类免疫缺陷病毒（HIV）感染，特别关注注射药物使用（IDU）和人类免疫缺陷的随之而来的流行病病毒（HIV），性传播疾病（STD）和结核病（TB）。到将Pirogov医科大学发展成为一个区域培训中心，卓越的研究，我们设计了一项培训计划，可以准备皮罗戈夫学者和学生解决有关的所有关键问题乌克兰与IDU相关的临床，运营和健康服务研究有效地参与解决全球问题的研究在HIV/STD/TB预防和控制中强调社区具有实质性的社区 IDU人群。我们的培训计划是多学科的，包括临床研究，国际健康，流行病学，健康行为，干预和治疗研究。我们的研究目标是更好地了解IDU 乌克兰流行病，以指导治疗和控制策略至于升级基于证据的方法，以了解艾滋病毒密切相关的流行病在其控制和预防的服务中，感染，性病和结核病。这 Pirogov医科大学作为关键培训中心的选择已完成考虑到四个关键因素：（1）Pirogov是主要的医疗之一东欧的学校；（2）Pirogov的四分之一的医疗学生来自乌克兰以外，成为国际培训地点; （3）Pirogov和UAB一直在研究和培训两年多来，有书面的实质性协议由Pirogov医科大学和UAB的教务长共同签名 2000年3月在伯明翰；（4）UAB和NDRI具有互补的专业知识并有密切的工作关系。